Objective To investigate the variation of coagulation and fibrinolytic molecular markers in tumor patients and their relationship with tumor incidence and development.

• 目的观察恶性肿瘤患者凝血及纤溶分子标志物的变化，以探索其发生、发展与止凝血的关系。